Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("BIODISPONIBILITE PRINCIPE ACTIF")

Document Type [dt]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Language

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 47

  • Page / 2
Export

Selection :

  • and

VERFUEGBARKEITSPRUEFUNG IN VITRO-ERFORDERNIS, MOEGLICHKEITEN, GRENZEN = RECHERCHE DE LA BIODISPONIBILITE IN VITRO. EXIGENCES, POSSIBILITES, LIMITESDIBBERN HW.1973; PHARM. INDUSTR.; DTSCH.; DA. 1973; VOL. 35; NO 2; PP. 76-78; ABS. ANGL.; BIBL. 50 REF.Serial Issue

PREDICTION OF SYSTEMIC AVAILABILITY FROM PLASMA-LEVEL DATA AFTER ORAL DRUG ADMINISTRATION = LA PREDICTION DE LA DISPONIBILITE GENERALE D'APRES LES DONNEES DU TAUX PLASMATIQUE APRES L'ADMINISTRATION PER OS DES MEDICAMENTSPERRIER D; GIBALDI M; BOYES RN et al.1973; J. PHARM. PHARMACOL.; G.B.; DA. 1973; VOL. 25; NO 3; PP. 256-257; BIBL. 7 REF.Serial Issue

BIOPHARMAZIE DER INJEKTABILIA. I. INJECTABILIA MIT SOFORTWIRKUNG = BIOPHARMACIE DES PRODUITS INJECTABLES. I. PRODUITS INJECTABLES AVEC UNE ACTION IMMEDIATE1973; PHARM. INDUSTR.; DTSCH.; DA. 1973; VOL. 35; NO 5; PP. 273-285; ABS. ANGL.; BIBL. 119REF.Serial Issue

BIOPHARMACEUTICAL STUDIES OF COMMERCIAL HYDROCHLOROTHIAZIDE FORMULATIONSMCGILVERAY IJ; HOSSIE RD; MATTOK GL et al.1973; CANAD. J. PHARM. SCI.; CANADA; DA. 1973; VOL. 8; NO 1; PP. 13-15; ABS. FR.; BIBL. 9 REF.Serial Issue

BIOAVAILABILITY OF POTASSIUM FROM A SLOW-RELEASE TABLET = LA BIODISPONIBILITE DU POTASSIUM A PARTIR DE COMPRIMES AVEC LIBERATION LENTEBEN ISHAY D; ENGELMAN K.1973; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1973; VOL. 14; NO 2; PP. 250-258; BIBL. 9REF.Serial Issue

BIOPHARMACEUTICAL EVALUATION OF CYANIDANOL TABLETS USING PHARMACOKINETIC TECHNIQUES = EVALUATION BIOPHARMACEUTIQUE DES COMPRIMES DE CYANIDANOL EN UTILISANT DES TECHNIQUES PHARMACOCINETIQUESGILES AR; GUMMA A.1973; ARZNEIMITTEL-FORSCH.; DTSCH.; DA. 1973; VOL. 23; NO 1; PP. 99-100; ABS. ALLEM.; BIBL. 9 REF.Serial Issue

BIOLOGICAL AND PHARMACOKINETIC EVIDENCE FOR GENERIC EQUIVALENCE OF THREE IMIPRAMINE PREPARATIONS: COMPARISON WITH A NEW IMIPRAMINE ANALOGUE = DEMONSTRATION BIOLOGIQUE ET PHARMACOCINETIQUE DE L'EQUIVALENCE GENERIQUE DE 3 PREPARATIONS D'IMIPRAMINE: COMPARAISON AVEC UN NOUVEL ANALOGUE DE L'IMIPRAMINETUCK JR; KAHAN E; SIWERS B et al.1973; ACTA PHARMACOL. TOXICOL.; DANEM.; DA. 1973; VOL. 32; NO 3-4; PP. 304-313; BIBL. 1P.1/2Serial Issue

CALCULATION OF ABSORPTION RATE CONSTANTS FOR DRUGS WITH INCOMPLETE AVAILABILITY = CALCUL DES CONSTANTES DES VITESSES D'ABSORPTION POUR LES MEDICAMENTS AVEC UNE DISPONIBILITE INCOMPLETEPERRIER D; GIBALDI M.1973; J. PHARM. SCI.; U.S.A.; DA. 1973; VOL. 62; NO 2; PP. 225-228; BIBL. 10REF.Serial Issue

ROLE OF DRUG METABOLISM IN DRUG RESEARCH AND DEVELOPMENT: IMPORTANCE OF DRUG METABOLISM IN CLINICAL PHARMACOLOGICAL EVALUATION OF NEW DRUGSLEMBERGER L.1972; J. PHARM. SCI.; U.S.A.; DA. 1972; VOL. 61; NO 10; PP. 1690-1694; BIBL. 22REF.Serial Issue

CORTICOSTEROID OINTMENTS: COMPARISON BY TWO HUMAN BIOASSAYS = POMMADE AUX CORTICOSTEROIDES: COMPARAISON DE DEUX ESSAIS BIOLOGIQUES SUR L'HOMMEBURDICK KH; HALEBLIAN JK; POULSEN BJ et al.1973; CURR. THERAPEUT. RES.; U.S.A.; DA. 1973; VOL. 15; NO 5; PP. 233-242; BIBL. 12REF.Serial Issue

PHARMACOLOGIE CLINIQUE ET CONTROLE DES MEDICAMENTSFRIEBEL H.1973; CHRON. O.M.S.; SUISSE; DA. 1973; VOL. 27; NO 3; PP. 94-98; BIBL. 10 REF.Serial Issue

VARIATIONS IN THEOPHYLLINE, EPHEDRINE HYDROCHLORIDE AND PHENOBARBITAL TABLETS MANUFACTURED BY THIRTEEN FIRMSLACH JL; TING FONG CHIN; PARROTT EL et al.1972; AMER. J. HOSP. PHARM.; U.S.A.; DA. 1972; VOL. 29; NO 12; PP. 1043-1047; BIBL. 9 REF.Serial Issue

COMPARATIVE BIOAVAILABILITY OF THREE BRANDS OF AMPICILLIN1972; CANAD. MED. ASS. J.; CANADA; DA. 1972; VOL. 107; NO 3; PP. 203-209; ABS. FR.; BIBL. 20 REF.Serial Issue

ASPECTS BIOPHARMACEUTIQUES DES PREPARATIONS MEDICAMENTEUSE PAR VOIE RECTALENEUWALD F.1972; PHARMA INTERNATION.; ALLEM.; DA. 1972; NO 2; PP. 5-11 (6P.); BIBL. 11REF.Serial Issue

INFLUENCE OF FIRST-PASS EFFECT ON THE SYSTEMIC AVAILABILITY OF PROPOXYPHENE = INFLUENCE DE L'EFFET D'UN PREMIER PASSAGE SUR LA DISPONIBILITE GENERALE DU PROPOXYPHENEPERRIER D; GIBALDI M.1972; J. CLIN. PHARMACOL.; U.S.A.; DA. 1972; VOL. 12; NO 11-12; PP. 449-452; BIBL. 13 REF.Serial Issue

ROCEEDINGS OF THE CONFERENCE ON BIOAVAILABILITY OF DRUGS AT THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES, WASHINGTON, D.C., NOVEMBER 22-23, 1971 = COMPTE RENDUS DE LA CONFERENCE SUR LA BIODISPONIBILITE DES MEDICAMENTS A L'ACADEMIE NATIONALE DES SCIENCES DES ETATS-UNIS, WASHINGTON, D.C., 22-23 NOVEMBRE 19711972; PHARMACOLOGY; SWITZ.; DA. 1972; VOL. 8; NO 1-3; PP. 3-215; BIBL. DISSEM.Serial Issue

THE BIOAVAILABILITY OF DIGOXIN = L'EFFICACITE BIOLOGIQUE DE LA DIGOXINE1972; LANCET; G.B.; DA. 1972; NO 7772; PP. 311-312Serial Issue

CORRELACION ENTRE LA LIBERACION DE PROXIFILINA IN VITRO A PARTIR DE SUPOSITORIOS Y RESULTADOS IN VIVO OBTENIDOS MEDIANTE ESTUDIOS DE EXCRECION URINARIA ACCUMULATIVA = CORRELATION ENTRE LA LIBERATION DE PROXYPHYLLINE IN VITRO A PARTIR DE SUPPOSITOIRES ET LES RESULTATS IN VIVO OBTENUS A PARTIR D'ETUDE D'EXCRETION URINAIRE ACCUMULATIVERITSCHEL WA; BANARER M.1972; BOL. SOC. QUIM. PERU; PERU; DA. 1972; VOL. 38; NO 4; PP. 212-227; H.T. 1; ABS. ANGL.; BIBL. 1P.1/2Serial Issue

VALUTAZIONE CLINICA IN GERIATRIA E INDAGINI DI BIODISPONIBILITA SU UN NUOVO FARMACO BENZODIAZEPINICO: IL LORAZEPAM = VALEUR CLINIQUE EN GERIATRIE ET ETUDE DE LA BIODISPONIBILITE D'UN NOUVEAU DERIVE DE LA BENZODIAZEPINE: LE LORAZEPAMAMORE A; DELPIANO G; MARDENTE S et al.1972; GAZZ. MED. ITAL.; ITAL.; DA. 1972; VOL. 131; NO 12; PP. 608-621; ABS. ANGL.; BIBL. 15REF.Serial Issue

GENERIC EQUIVALENCE: A LOOK AT THE LITERATUREFLORENCE AT.1972; INDIAN J. PHARM.; INDIA; DA. 1972; VOL. 34; NO 6; PP. 129-146; BIBL. 2 P.Serial Issue

THE ABSORPTION AND METABOLISM IN MAN OF 4-ACETAMIDOPHENYL-2-ACETOXYBENZOATE (BENORYLATE)ROBERTSON A; GLYNN JP; WATSON AK et al.1972; XENOBIOTICA; G.B.; DA. 1972; VOL. 2; NO 4; PP. 339-347; BIBL. 16 REF.Serial Issue

THE PHYSIOLOGICAL AVAILABILITY OF METHAMPHETAMINE HCL = DISPONIBILITE PHYSIOLOGIQUE DE LA METHAMPHETAMINE HCLKASIRSKY G; LAWLESS GB.1972; RES. COMMUNIC. CHEM. PATHOL. PHARMACOL.; U.S.A.; DA. 1972; VOL. 4; NO 2; PP. 289-296; BIBL. 1P.Serial Issue

VARIATION IN THE BIOLOGICAL AVAILABILITY OF DIGOXIN = VARIATION DE L'EFFICACITE BIOLOGIQUE DE LA DIGOXINESHAW TRD; HOWARD MR; HAMER J et al.1972; LANCET; G.B.; DA. 1972; NO 7772; PP. 303-307; BIBL. 16REF.Serial Issue

IN VITRO-VERSUCHE ZUM PROBLEM GALENISCHE ZUBEREITUNGEN ODER REINSUBSTANZ = ESSAIS IN VITRO CONCERNANT: LES PREPARATIONS GALENIQUES OU LES SUBSTANCES PURESCSUPOR L.1972; PLANTA MED.; ALLEM.; DA. 1972; VOL. 22; NO 4; PP. 365-377; ABS. ANGL.; BIBL. 1P.Serial Issue

EINE NEUE GALENISCHE ZUBEREITUNGSFORM ORALER PENICILLINE = UNE NOUVELLE FORME DE PREPARATION GALENIQUE DE LA PENICILLINE ORALEDIMMLING T.1973; MED. KLIN.; DTSCH.; DA. 1973; VOL. 68; NO 4; PP. 119-123; BIBL. 11 REF.Serial Issue

  • Page / 2